T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
TriNet
TNET
$3.31B
| $24.5M | ﹤0.01% |
244,633
+8,630
| +4% | +$863K |
|
902
Immunome
IMNM
$782M
| $24.5M | ﹤0.01% |
2,021,119
-224,554
| -10% | -$2.72M |
|
903
Green Brick Partners
GRBK
$3.13B
| $24.3M | ﹤0.01% |
425,048
-86,434
| -17% | -$4.95M |
|
904
Jacobs Solutions
J
$17.6B
| $24.3M | ﹤0.01% |
210,321
+6,173
| +3% | +$713K |
|
905
T. Rowe Price Growth Stock ETF
TGRW
$884M
| $24.2M | ﹤0.01% |
+650,001
| New | +$24.2M |
|
906
Principal Financial Group
PFG
$18B
| $24.2M | ﹤0.01% |
307,878
+6,557
| +2% | +$514K |
|
907
MGM Resorts International
MGM
$9.61B
| $24.1M | ﹤0.01% |
541,448
-21,996
| -4% | -$978K |
|
908
Clorox
CLX
$15.3B
| $23.9M | ﹤0.01% |
175,342
+2,575
| +1% | +$351K |
|
909
CNX Resources
CNX
$4.38B
| $23.8M | ﹤0.01% |
980,244
+867,985
| +773% | +$21.1M |
|
910
Labcorp
LH
$22.9B
| $23.8M | ﹤0.01% |
117,045
+2,557
| +2% | +$520K |
|
911
Waters Corp
WAT
$18.1B
| $23.7M | ﹤0.01% |
81,852
+1,539
| +2% | +$447K |
|
912
Citizens Financial Group
CFG
$22.6B
| $23.6M | ﹤0.01% |
654,003
+12,430
| +2% | +$448K |
|
913
Amphastar Pharmaceuticals
AMPH
$1.25B
| $23.4M | ﹤0.01% |
583,906
-638
| -0.1% | -$25.5K |
|
914
iRhythm Technologies
IRTC
$5.53B
| $23.3M | ﹤0.01% |
216,759
-3,862
| -2% | -$416K |
|
915
Invesco
IVZ
$9.88B
| $23.2M | ﹤0.01% |
1,552,428
+55,023
| +4% | +$823K |
|
916
ADMA Biologics
ADMA
$3.72B
| $23.2M | ﹤0.01% |
2,076,328
+2,015,404
| +3,308% | +$22.5M |
|
917
Photronics
PLAB
$1.38B
| $23.2M | ﹤0.01% |
938,445
+97,907
| +12% | +$2.42M |
|
918
Arm
ARM
$162B
| $23.1M | ﹤0.01% |
140,999
-149,948
| -52% | -$24.5M |
|
919
NRG Energy
NRG
$31.8B
| $23M | ﹤0.01% |
296,002
-20,842
| -7% | -$1.62M |
|
920
LeMaitre Vascular
LMAT
$2.08B
| $23M | ﹤0.01% |
279,282
+273,639
| +4,849% | +$22.5M |
|
921
Academy Sports + Outdoors
ASO
$3.1B
| $23M | ﹤0.01% |
431,446
-30,972
| -7% | -$1.65M |
|
922
Allegion
ALLE
$15.2B
| $22.8M | ﹤0.01% |
193,301
-36,600
| -16% | -$4.32M |
|
923
Mid-America Apartment Communities
MAA
$16.3B
| $22.8M | ﹤0.01% |
159,668
+3,762
| +2% | +$537K |
|
924
CRISPR Therapeutics
CRSP
$5.37B
| $22.7M | ﹤0.01% |
420,695
-179,539
| -30% | -$9.7M |
|
925
Warner Bros
WBD
$44.6B
| $22.7M | ﹤0.01% |
3,047,787
+56,947
| +2% | +$424K |
|